Compile Data Set for Download or QSAR
maximum 50k data
Found 139 with Last Name = 'felding' and Initial = 'j'
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130938(US8829190, 116)
Affinity DataIC50:  0.100nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130937(US8829190, 115)
Affinity DataIC50:  0.200nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130939(US8829190, 117)
Affinity DataIC50:  0.200nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130933(US8829190, 111)
Affinity DataIC50:  0.300nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130936(US8829190, 114)
Affinity DataIC50:  0.400nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130932(US8829190, 110)
Affinity DataIC50:  0.5nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130935(US8829190, 113)
Affinity DataIC50:  0.700nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048422(CHEMBL3315084)
Affinity DataIC50:  1nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130934(US8829190, 112)
Affinity DataIC50:  1nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130923(US8829190, 101)
Affinity DataIC50:  2nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130940(US8829190, 118)
Affinity DataIC50:  3nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048421(CHEMBL3315083)
Affinity DataIC50:  3nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130950(US8829190, 128)
Affinity DataIC50:  3nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130928(US8829190, 106)
Affinity DataIC50:  4nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048446(CHEMBL3315088)
Affinity DataIC50:  5nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048447(CHEMBL3315089)
Affinity DataIC50:  5nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130925(US8829190, 103)
Affinity DataIC50:  7nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048476(CHEMBL3315079)
Affinity DataIC50:  8nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130941(US8829190, 119)
Affinity DataIC50:  8nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048477(CHEMBL3315080)
Affinity DataIC50:  11nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048463(CHEMBL3315072)
Affinity DataIC50:  13nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048443(CHEMBL3315087)
Affinity DataIC50:  13nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048474(CHEMBL3315077)
Affinity DataIC50:  15nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048478(CHEMBL3315081)
Affinity DataIC50:  17nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50041866(CHEMBL48017 | N-(3,5-Dichloro-pyridin-4-yl)-3,4-di...)
Affinity DataIC50:  17nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048424(CHEMBL3315086)
Affinity DataIC50:  17nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048455(CHEMBL3315090)
Affinity DataIC50:  20nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130931(US8829190, 109)
Affinity DataIC50:  24nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130926(US8829190, 104)
Affinity DataIC50:  26nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130929(US8829190, 107)
Affinity DataIC50:  45nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048475(CHEMBL3315078)
Affinity DataIC50:  45nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130949(US8829190, 127)
Affinity DataIC50:  46nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130946(US8829190, 124)
Affinity DataIC50:  52nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130930(US8829190, 108)
Affinity DataIC50:  55nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048423(CHEMBL3315085)
Affinity DataIC50:  61nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048473(CHEMBL3315076)
Affinity DataIC50:  63nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130945(US8829190, 123)
Affinity DataIC50:  68nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048470(CHEMBL3313943)
Affinity DataIC50:  81nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048464(CHEMBL3315073)
Affinity DataIC50:  110nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130924(US8829190, 102)
Affinity DataIC50:  134nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDNA gyrase subunit A/B(Staphylococcus aureus)
Technical University Of Denmark

Curated by ChEMBL
LigandPNGBDBM50596272(CHEMBL5199813)
Affinity DataIC50:  190nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase supercoiling activity using pNO1 plasmid DNA as substrate incubated for 30 mins by fluorescence based ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Homo sapiens (Human))
Leo Pharma

Curated by ChEMBL
LigandPNGBDBM50048471(CHEMBL3315074)
Affinity DataIC50:  212nMAssay Description:Inhibition of human recombinant PDE4D after 1 hr by SPA in presence of radioactively labeled cAMPMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDNA gyrase subunit A/B(Escherichia coli (strain K12))
Technical University Of Denmark

Curated by ChEMBL
LigandPNGBDBM21690(1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,...)
Affinity DataIC50:  230nMAssay Description:Inhibition of Escherichia coli DNA gyrase by fluorescence based microtiter plate reader assayMore data for this Ligand-Target Pair
In DepthDetails PubMedDrugBank

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130944(US8829190, 122)
Affinity DataIC50:  261nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDNA gyrase subunit A/B(Staphylococcus aureus)
Technical University Of Denmark

Curated by ChEMBL
LigandPNGBDBM50596263(CHEMBL5207657)
Affinity DataIC50:  280nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase supercoiling activity using pNO1 plasmid DNA as substrate incubated for 30 mins by fluorescence based ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA gyrase subunit A/B(Staphylococcus aureus)
Technical University Of Denmark

Curated by ChEMBL
LigandPNGBDBM50596278(CHEMBL5178214)
Affinity DataIC50:  280nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase supercoiling activity using pNO1 plasmid DNA as substrate incubated for 30 mins by fluorescence based ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4A(Homo sapiens (Human))
Leo Pharma

US Patent
LigandPNGBDBM130927(US8829190, 105)
Affinity DataIC50:  305nMAssay Description:Human recombinant PDE4 (Gene bank accession no NM006203) was incubated for 1 hour with the test compound at concentrations up to 10 μM, with cAM...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDNA gyrase subunit A/B(Staphylococcus aureus)
Technical University Of Denmark

Curated by ChEMBL
LigandPNGBDBM50393503(CHEMBL2158050)
Affinity DataIC50:  340nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase supercoiling activity using pNO1 plasmid DNA as substrate incubated for 30 mins by fluorescence based ...More data for this Ligand-Target Pair
In DepthDetails PubMed
TargetDNA gyrase subunit A/B(Staphylococcus aureus)
Technical University Of Denmark

Curated by ChEMBL
LigandPNGBDBM50596261(CHEMBL5176134)
Affinity DataIC50:  370nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase supercoiling activity using pNO1 plasmid DNA as substrate incubated for 30 mins by fluorescence based ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
TargetDNA gyrase subunit A/B(Staphylococcus aureus)
Technical University Of Denmark

Curated by ChEMBL
LigandPNGBDBM50596275(CHEMBL5176348)
Affinity DataIC50:  370nMAssay Description:Inhibition of Staphylococcus aureus DNA gyrase supercoiling activity using pNO1 plasmid DNA as substrate incubated for 30 mins by fluorescence based ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails PubMed
Displayed 1 to 50 (of 139 total ) | Next | Last >>
Jump to: